{Reference Type}: Journal Article
{Title}: Integrin Alpha v Beta 6 (αvβ6) and Its Implications in Cancer Treatment.
{Author}: Brzozowska E;Deshmukh S;
{Journal}: Int J Mol Sci
{Volume}: 23
{Issue}: 20
{Year}: Oct 2022 15
{Factor}: 6.208
{DOI}: 10.3390/ijms232012346
{Abstract}: Integrins are necessary for cell adhesion, migration, and positioning. Essential for inducing signalling events for cell survival, proliferation, and differentiation, they also trigger a variety of signal transduction pathways involved in mediating invasion, metastasis, and squamous-cell carcinoma. Several recent studies have demonstrated that the up- and down-regulation of the expression of αv and other integrins can be a potent marker of malignant diseases and patient prognosis. This review focuses on an arginine-glycine-aspartic acid (RGD)-dependent integrin αVβ6, its biology, and its role in healthy humans. We examine the implications of αVβ6 in cancer progression and the promotion of epithelial-mesenchymal transition (EMT) by contributing to the activation of transforming growth factor beta TGF-β. Although αvβ6 is crucial for proper function in healthy people, it has also been validated as a target for cancer treatment. This review briefly considers aspects of targeting αVβ6 in the clinic via different therapeutic modalities.